Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Realize is a healthcare technology company that develops artificial intelligence solutions to improve medical imaging workflows, specifically for lung cancer screening. The company's flagship platform utilizes deep learning to automate the detection, measurement, and longitudinal tracking of lung nodules in CT scans. By providing standardized and objective data, Realize aims to assist radiologists in identifying early-stage malignancies more accurately and efficiently. The platform is designed for seamless integration into existing clinical environments, helping healthcare providers manage screening programs and improve patient outcomes through earlier intervention. Their technology focuses on reducing the administrative and cognitive burden on clinicians while ensuring high-risk findings are prioritized.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Realize.ai.